Goldfarb Branham LLP is investigating whether the Board of Directors of MedQuist, Inc. (NASDAQ: MEDQ) violated shareholder protection laws in connection with the proposed...
Levi & Korsinsky is investigating the Board of Directors of MedQuist Inc. (“MedQuist” or the “Company”) (Nasdaq: MEDQ) for possible breaches of fiduciary duty and other...
Tripp Levy PLLC, a leading national securities firm, announces an investigation into the proposed acquisition of MedQuist Inc. (NASDAQ: MEDQ). On January 21, 2011, CBaySystems...
MedQuist Names Anthony D. James as Chief Financial Officer PR Newswire MOUNT LAUREL, N.J., Nov. 22, 2010 MOUNT LAUREL, N.J., Nov. 22, 2010 /PRNewswire-FirstCall/ -- MedQuist Inc., (Nasdaq: MEDQ...
MedQuist Reports Third Quarter 2010 Results PR Newswire MOUNT LAUREL, N.J., Nov. 11, 2010 MOUNT LAUREL, N.J., Nov. 11, 2010 /PRNewswire-FirstCall/ -- MedQuist Inc., (Nasdaq: MEDQ) a leading...
MedQuist's Majority Owner Files Form S-1 and Form S-4 Registration Statements PR Newswire MOUNT LAUREL, N.J., Oct. 18 MOUNT LAUREL, N.J., Oct. 18 /PRNewswire-FirstCall/ -- MedQuist Inc. (Nasdaq:...
MedQuist Announces Closing of Financing and NASDAQ Determination of Ex-Dividend Date of October 18 for Special Dividend PR Newswire MOUNT LAUREL, N.J., Oct. 14 MOUNT LAUREL, N.J., Oct. 14...
MedQuist Provides Update on Special Dividend Timing PR Newswire MOUNT LAUREL, N.J., Oct. 8 MOUNT LAUREL, N.J., Oct. 8 /PRNewswire-FirstCall/ -- MedQuist Inc. (Nasdaq: MEDQ), a leading provider of...
MedQuist Signs Financing Agreements; Declares Special Dividend PR Newswire MOUNT LAUREL, N.J., Oct. 1 MOUNT LAUREL, N.J., Oct. 1 /PRNewswire-FirstCall/ -- MedQuist Inc. (Nasdaq: MEDQ), a leading...
MedQuist Introduces CodeRunner™ With Computer-Assisted Coding Automated Coding Solution Positions Healthcare Providers for ICD-10 PR Newswire MT. LAUREL, N.J., Sept. 28 MT. LAUREL, N.J., Sept. 28...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales